AD/PD 2027 – Advances in Science & Therapy
16 March 2027 – 20 March 2027
Centre de Convencions Internacional de Barcelona, Barcelona, Spain
AD/PD™ 2027 is the 21st International Conference on Alzheimer's and Parkinson's Diseases and related disorders, an annual meeting focused on advances in science and therapy for neurodegenerative diseases. Held as a hybrid conference in Barcelona, Spain, and online on March 16–20, 2027, it combines Alzheimer's, Parkinson's and other related neurodegenerative diseases in one setting to examine their similarities and differences, with emphasis on mechanisms of disease, biomarkers and diagnosis, drug development, clinical trials, prevention and therapy.
125 sessions · 530 speakers
Media Partners (4)
touchNEUROLOGY · Karger · Parkinson's Europe · Oruen
Sponsors (10)
Danaher · Illumina · Annovis Bio · Sanofi · BIOGEN · Sysmex Europe SE · Eli Lilly and Company · Parexel · Bristol Myers Squibb · Cure Alzheimer's Fund
Association Partners (2)
Dansk Neurologisk Selskab · Danish Society of Neuroimmunology
Exhibitors (28)
Scantox · GSL · StressMarq Biosciences · Cell Signaling Technology · Danaher · Beacon Biosignals · Illumina · Siemens Healthineers · Altheome · BIOGEN · PSI CRO · FYR Bio · Dasher Neuroscience Inc. · Sysmex Europe SE · WuXi AppTec · betaSENSE GmbH · Nightingale Health · Eli Lilly and Company · VectorBuilder Ltd · Parexel · Lipotype GmbH · Innoprot · Bristol Myers Squibb · Huabio · InnoSer · MagQu Co. Ltd. (Taiwan) · Noselab GmbH · FUJIFILM Cellular Dynamics, Inc.
Agenda
- ON - DEMAND SYMPOSIA (VIRTUAL GALLERY) - Online Only 16 March 2027 · On-Demand Virtual Gallery
- INDUSTRY SYMPOSIUM (NONE CME/CPD CREDIT) 16 March 2027 · Auditorium
- PSP: FROM TAU BIOLOGY TO THERAPEUTICS 16 March 2027 · Hall 113
- INVITED SYMPOSIUM (NONE CME/CPD CREDIT) BY INVITATION ONLY 16 March 2027 · Hall 212
- LATE BREAKING SYMPOSIUM 16 March 2027 · Hall 114
- GLIA IN ACTION: SHAPING ALZHEIMER’S DISEASE 16 March 2027 · Hall 117
- INVITED SYMPOSIUM (NONE CME/CPD CREDIT) BY INVITATION ONLY 16 March 2027 · Hall 111
- APOE4 ACROSS CELLS AND SYSTEMS: MECHANISMS DRIVING AD 16 March 2027 · Hall 115+116
- DECODING ALZHEIMER’S: GENES, ANCESTRY & OMICS 16 March 2027 · Hall 112
- INVITED SYMPOSIUM (NONE CME/CPD CREDIT) BY INVITATION ONLY 16 March 2027 · Hall 111
- FROM SYNAPSES TO NETWORKS IN AD 16 March 2027 · Hall 112
- TRANSFORMING PARKINSON’S: FROM TREATMENT TO PREVENTION 16 March 2027 · Hall 117
- INVITED SYMPOSIUM (NONE CME/CPD CREDIT) BY INVITATION ONLY 16 March 2027 · Hall 212
- LATE BREAKING SYMPOSIUM 16 March 2027 · Hall 114
- MICROGLIA: SIGNALS, STATES & THERAPEUTIC TARGETS 16 March 2027 · Hall 115+116
- FROM CELLS TO BIOMARKERS 16 March 2027 · Hall 113
- INDUSTRY SYMPOSIUM (NONE CME/CPD CREDIT) 16 March 2027 · Auditorium
- APOE AND BEYOND: ALZHEIMER’S GENETICS ACROSS ANCESTRIES 16 March 2027 · Hall 113
- CHOLINERGIC VULNERABILITY IN ALZHEIMER’S AND LEWY BODY DISEASE 16 March 2027 · Hall 112
- THE GENETIC SPECTRUM OF NEURODEGENERATION: FROM MUTATIONS TO POLYGENIC RISK 16 March 2027 · Hall 115+116
- INVITED SYMPOSIUM (NONE CME/CPD CREDIT) BY INVITATION ONLY 16 March 2027 · Hall 212
- LATE BREAKING SYMPOSIUM 16 March 2027 · Hall 114
- INDUSTRY SYMPOSIUM (NONE CME/CPD CREDIT) 16 March 2027 · Auditorium
- AMYLOID & TAU: RETHINKING ALZHEIMER’S PATHOGENESIS 16 March 2027 · Hall 117
- INVITED SYMPOSIUM (NONE CME/CPD CREDIT) BY INVITATION ONLY 16 March 2027 · Hall 111
- GLOBAL LEADERSHIP FORUM: MOONSHOTS & MILESTONES: WHO WILL OWN THE FUTURE OF NEURODEGENERATION? 16 March 2027 · Auditorium
- PLENARY LECTURE 1, 2 16 March 2027 · Auditorium
- OPENING CEREMONY AND AWARDS 16 March 2027 · Auditorium
- ON - DEMAND SYMPOSIA (VIRTUAL GALLERY) - Online Only 17 March 2027 · On-Demand Virtual Gallery
- PLENARY LECTURE 3, 4 17 March 2027 · Auditorium
- FROM MODELS TO MEDICINES IN AD 17 March 2027 · Hall 113
- RESILIENCE TO ALZHEIMER’S: FROM BIOLOGY TO PREVENTION 17 March 2027 · Hall 117
- LATE BREAKING SYMPOSIUM 17 March 2027 · Hall 212
- RISK, BIOMARKERS AND RESILIENCE IN PRECLINICAL AD 17 March 2027 · Hall 114
- INDUSTRY SYMPOSIUM (NONE CME/CPD CREDIT) 17 March 2027 · Auditorium
- EMERGING FLUID BIOMARKERS AND PROTEOMIC SIGNATURES IN AD 17 March 2027 · Hall 111
- PATHOBIOLOGY AND BIOMARKERS OF Α-SYNUCLEINOPATHIES 17 March 2027 · Hall 112
- CHOLINERGIC CIRCUIT DYSFUNCTION AND THERAPEUTIC TARGETING IN DEMENTIA 17 March 2027 · Hall 115+116
- INDUSTRY SYMPOSIUM (NONE CME/CPD CREDIT) 17 March 2027 · Auditorium
- INDUSTRY SYMPOSIUM (NONE CME/CPD CREDIT) 17 March 2027 · Auditorium
- FROM PHENOTYPE TO BIOLOGY IN SYNUCLEINOPATHIES 17 March 2027 · Hall 111
- METABOLIC DYSREGULATION ACROSS ALZHEIMER’S AND SYNUCLEINOPATHIES 17 March 2027 · Hall 113
- NEUROVASCULAR DYSFUNCTION AND CEREBRAL AMYLOID ANGIOPATHY IN AD 17 March 2027 · Hall 114
- PD: PREDICTING PROGRESSION, TREATMENT RESPONSE & REAL-WORLD OUTCOMES 17 March 2027 · Hall 212
- BIOMARKERS THAT DECIDE: ARE WE READY TO TREAT BEFORE SYMPTOMS? 17 March 2027 · Hall 115+116
- APOE-DEPENDENT MECHANISMS ACROSS NEURODEGENERATIVE DISEASES 17 March 2027 · Hall 112
- GENETIC RISK, MOLECULAR MECHANISMS AND DISEASE PROGRESSION IN SYNUCLEINOPATHIES 17 March 2027 · Hall 117
- AI → IMPACT: CAN DATA-DRIVEN BIOLOGY DELIVER REAL DISEASE-MODIFYING THERAPIES?? 17 March 2027 · Hall 115+116
- INDUSTRY SYMPOSIUM (NONE CME/CPD CREDIT) 17 March 2027 · Auditorium
- ON - DEMAND SYMPOSIA (VIRTUAL GALLERY) - Online Only 18 March 2027 · On-Demand Virtual Gallery
- PLENARY LECTURE 5 18 March 2027 · Auditorium
- SYMPOSIUM 18 March 2027 · Hall 212
- ARTIFICIAL INTELLIGENCE AND DIGITAL TECHNOLOGIES IN NEURODEGENERATIVE DISEASES 18 March 2027 · Hall 112
- FROM BIOMARKERS TO DIAGNOSIS: TRANSFORMING DEMENTIA CARE 18 March 2027 · Hall 117
- FROM CAA TO ARIA: UNDERSTANDING VASCULAR VULNERABILITY 18 March 2027 · Hall 115+116
- INDUSTRY SYMPOSIUM (NONE CME/CPD CREDIT) 18 March 2027 · Auditorium
- MAPPING AD PROGRESSION: FROM PATHOLOGY TO NEURODEGENERATION 18 March 2027 · Hall 114
- NEUROPATHOLOGICAL HETEROGENEITY AND IN VIVO DETECTION OF NEURODEGENERATIVE PROTEINOPATHIES 18 March 2027 · Hall 113
- REWRITING NEURODEGENERATION: FROM PROTEIN TARGETING TO GENE EDITING 18 March 2027 · Hall 111
- INDUSTRY SYMPOSIUM (NONE CME/CPD CREDIT) 18 March 2027 · Auditorium
- MOLECULAR MECHANISMS AND THERAPEUTIC TARGETING OF LRRK2 IN PD 18 March 2027 · Hall 114
- INDUSTRY SYMPOSIUM (NONE CME/CPD CREDIT) 18 March 2027 · Auditorium
- THE VULNERABLE SYNAPSE: FROM MECHANISMS TO BIOMARKERS 18 March 2027 · Hall 111
- SYMPOSIUM 18 March 2027 · Hall 212
- GENETIC, BIOMARKER AND IMAGING HETEROGENEITY OF CEREBRAL SMALL-VESSEL DISEASE 18 March 2027 · Hall 113
- BIOMARKERS ACROSS THE SYNUCLEINOPATHY CONTINUUM 18 March 2027 · Hall 112
- CENTRAL AND PERIPHERAL IMMUNE MECHANISMS IN NEURODEGENERATIVE DISEASE 18 March 2027 · Hall 117
- OPTIMISING THERAPY: PROMISING COMBINATION STRATEGIES IN AD AND PD 18 March 2027 · Hall 115+116
- REWIRING THE FAILING BRAIN: CAN CIRCUIT-BASED THERAPIES DELIVER THE NEXT GENERATION OF CNS DRUGS? 18 March 2027 · Hall 115+116
- MRI BIOMARKERS OF PRODROMAL AND EARLY PARKINSON’S DISEASE 18 March 2027 · Hall 114
- PROTEOSTASIS AND MOLECULAR MECHANISMS OF TAU PATHOLOGY IN AD 18 March 2027 · Hall 117
- MOLECULAR FINGERPRINTS OF NEURODEGENERATION 18 March 2027 · Hall 111
- SYMPOSIUM 18 March 2027 · Hall 212
- MITOCHONDRIA, METABOLISM & NEURODEGENERATION 18 March 2027 · Hall 112
- INDUSTRY SYMPOSIUM (NONE CME/CPD CREDIT) 18 March 2027 · Auditorium
- THE NEXT ERA OF AD TREATMENT 18 March 2027 · Hall 115+116
- THE BIOLOGY OF COGNITIVE RESILIENCE 18 March 2027 · Hall 113
- ON - DEMAND SYMPOSIA (VIRTUAL GALLERY) - Online Only 19 March 2027 · On-Demand Virtual Gallery
- PLENARY LECTURE 6 19 March 2027 · Auditorium
- INDUSTRY SYMPOSIUM (NONE CME/CPD CREDIT) 19 March 2027 · Auditorium